| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RAD51 paralog D | 0.674 | 0.385 | 1.1E-09 |
|
disease | 0.510 | limited | 1.000 | 1 | 1 | 2000 | 2019 | ||||||||
|
microcephalin 1 | 0.540 | 0.846 | 7.8E-30 |
|
disease | 0.310 | limited | 1.000 | 1 | 0 | 2005 | 2016 | ||||||||
|
protein phosphatase, Mg2+/Mn2+ dependent 1D | 0.513 | 0.808 | 2.2E-11 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
disease | 0.310 | disputed | 1.000 | 1 | 1 | 2002 | 2018 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.310 | definitive | 1.000 | 1 | 0 | 1991 | 2018 | ||||||||
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.310 | disputed | 1.000 | 1 | 0 | 2003 | 2017 | ||||||||
|
testis expressed 15, meiosis and synapsis associated | 0.769 | 0.115 | 5.0E-25 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
protein tyrosine phosphatase receptor type G | 0.619 | 0.731 | 5.1E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2005 | 2005 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
period circadian regulator 1 | 0.556 | 0.731 | 2.9E-04 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
DNA polymerase eta | 0.663 | 0.462 | 3.5E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
SH3 domain containing ring finger 1 | 0.780 | 0.231 | 1.1E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ATR serine/threonine kinase | 0.456 | 0.923 | 3.5E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
microRNA 499a | 0.519 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
cancer/testis antigen 55 | 0.736 | 0.308 | 0.49 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
FA complementation group L | 0.551 | 0.731 | 5.9E-23 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
macrophage scavenger receptor 1 | 0.553 | 0.654 | 2.2E-20 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
mutS homolog 3 | 0.474 | 0.769 | 7.4E-31 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.010 | None | < 0.001 | 1 | 1 | 2012 | 2012 | ||||||||
|
lanosterol synthase | 0.606 | 0.654 | 1.8E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 |